CD4 and myeloid sarcoma: These data were in agreement with contemporary works showing a lack of differences between MS-discordant monozygotic twins in peripheral blood CD4+ T cells, and the increasing appreciation of the role of CD8+ T cells as pathogenic effectors in MS [68].